October 1, 2015
Novartis Announces NEJM Publication of Secukinumab Phase III
Novartis announced on Wednesday that results from the pivotal Phase III FUTURE 1 study for Secukinumab in psoriatic arthritis (PsA)…
pharmaceutical daily
Pharmaceuticals, Biotechnology and Life Sciences
September 30, 2015
Sanofi: FDA to review New Drug Application for Lixisenatide
Sanofi announced on Tuesday that the U.S. Food and Drug Administration (FDA) has accepted for filing the New Drug Application (NDA) for lixisenatide.
September 30, 2015
ImmuPharma:Tim McCarthy Appointed as Non-executive Chairman
ImmuPharma PLC the specialist drug discovery and development company, has announced the appointment of Tim McCarthy as Non-executive Chairman, with immediate effect.
September 30, 2015
Veidekke to build Danish Centre for Particle Therapy
Veidekke’s Danish subsidiary Hoffmann has been awarded a contract to build a new national research and treatment centre for particle therapy in Aarhus in Jutland.
September 30, 2015
FDA approves Meiji’s QIDP and Fast Track Designation to ME1100
Meiji Seika Pharma Co., Ltd. announced on Tuesday that the U.S. Food and Drug Administration (FDA) has designated the Company’s lead antibiotic product, ME1100 (arbekacin inhalation solution), as a Qualified Infectious Disease Product (QIDP) for the adjunctive treatment of mechanically ventilated patients with bacterial pneumonia.
September 29, 2015
Switzerland: Suspected crime connected with medicinal products. Swissmedic investigates
Several individuals in German-speaking Switzerland are suspected of offences against the Therapeutic Products Act.
September 29, 2015
Pfizer’s Sayana Press first self injectable contraceptive in UK
Pfizer Inc., the specialist in making contraceptive medicine, best known for making Viagra, has announced that its injectable contraceptive, Sayana Press (medroxyprogesterone acetate), is now available to women in the United Kingdom (UK) for administration by self-injection.
September 29, 2015
Teva’s COPAXONE approved in Japan for the Prevention of Relapse of Multiple Sclerosis
Teva Pharmaceutical Industries Ltd. announced on Monday that its glatiramer acetate injection was approved by the Japanese Ministry of Health, Labour and Welfare (MHLW)…
September 29, 2015
Esbriet shows Benefits for patients with idiopathic pulmonary fibrosis
New clinical data and abstracts on Roche’s Esbriet (pirfenidone) in the treatment of idiopathic pulmonary fibrosis (IPF) are being presented at the European Respiratory Society (ERS) congress in Amsterdam.
September 29, 2015
New European Oilseed Processing Center in Monheim, Germany
Bayer CropScience inaugurated its new European Oilseed Processing Center in Monheim at a ceremony attended by industry representatives, authorities, agricultural stakeholders and customers.